BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castañeda S, Nurmohamed MT, González-gay MA. Cardiovascular disease in inflammatory rheumatic diseases. Best Practice & Research Clinical Rheumatology 2016;30:851-69. [DOI: 10.1016/j.berh.2016.10.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 11.4] [Reference Citation Analysis]
Number Citing Articles
1 Liew JW, Ramiro S, Gensler LS. Cardiovascular morbidity and mortality in ankylosing spondylitis and psoriatic arthritis. Best Pract Res Clin Rheumatol 2018;32:369-89. [PMID: 31171309 DOI: 10.1016/j.berh.2019.01.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
2 Bai R, Zhang Y, Liu W, Ma C, Chen X, Yang J, Sun D. The Relationship of Ankylosing Spondylitis and Subclinical Atherosclerosis: A Systemic Review and Meta-Analysis. Angiology 2018;70:492-500. [DOI: 10.1177/0003319718814309] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
3 Berlin‐broner Y, Alexiou M, Levin L, Febbraio M. Characterization of a mouse model to study the relationship between apical periodontitis and atherosclerosis. Int Endod J 2020;53:812-23. [DOI: 10.1111/iej.13279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Navarini L, Caso F, Costa L, Currado D, Stola L, Perrotta F, Delfino L, Sperti M, Deriu MA, Ruscitti P, Pavlych V, Corrado A, Di Benedetto G, Tasso M, Ciccozzi M, Laudisio A, Lunardi C, Cantatore FP, Lubrano E, Giacomelli R, Scarpa R, Afeltra A. Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment. Rheumatol Ther 2020;7:867-82. [PMID: 32939675 DOI: 10.1007/s40744-020-00233-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ladehesa-Pineda ML, Arias de la Rosa I, López Medina C, Castro-Villegas MDC, Ábalos-Aguilera MDC, Ortega-Castro R, Gómez-García I, Seguí-Azpilcueta P, Jiménez-Gómez Y, Escudero-Contreras A, López Pedrera C, Barbarroja N, Collantes-Estévez E; CASTRO Working Group. Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis 2020;12:1759720X20982837. [PMID: 33447266 DOI: 10.1177/1759720X20982837] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Petcharat C, Srinonprasert V, Chiowchanwisawakit P. Association between syndesmophyte and metabolic syndrome in patients with psoriatic arthritis or ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord 2021;22:367. [PMID: 33879097 DOI: 10.1186/s12891-021-04222-8] [Reference Citation Analysis]
7 Sluijsmans DMCF, Rohrich DC, Popa CD, van den Bemt BJF. Angiotensin-Inhibiting Drugs Do Not Impact Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Cross-Sectional Study. J Clin Med 2021;10:1985. [PMID: 34063142 DOI: 10.3390/jcm10091985] [Reference Citation Analysis]
8 López-Mejías R, González-Gay MA. IL-6: linking chronic inflammation and vascular calcification. Nat Rev Rheumatol 2019;15:457-9. [PMID: 31235835 DOI: 10.1038/s41584-019-0259-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
9 Glick K, Novofastovski I, Schwartz N, Mader R. Cardiovascular disease in diffuse idiopathic skeletal hyperostosis (DISH): from theory to reality-a 10-year follow-up study. Arthritis Res Ther 2020;22:190. [PMID: 32807215 DOI: 10.1186/s13075-020-02278-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Hansen RB, Simard JF, Faurschou M, Jacobsen S. Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population. J Autoimmun 2021;123:102692. [PMID: 34364172 DOI: 10.1016/j.jaut.2021.102692] [Reference Citation Analysis]
11 Gonzalez-Martin C, Grande Morais S, Pertega-Diaz S, Seoane-Pillado T, Balboa-Barreiro V, Veiga-Seijo R. Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis. Cardiol Res Pract 2019;2019:7689208. [PMID: 31001432 DOI: 10.1155/2019/7689208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
12 Toussirot E, Marotte H, Mulleman D, Cormier G, Coury F, Gaudin P, Dernis E, Bonnet C, Damade R, Grauer JL, Abdesselam TA, Guillibert-Karras C, Lioté F, Hilliquin P, Sacchi A, Wendling D, Le Goff B, Puyraveau M, Dumoulin G. Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study. Arthritis Res Ther 2020;22:224. [PMID: 32993784 DOI: 10.1186/s13075-020-02297-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Robinson C, Tsang L, Solomon A, Woodiwiss AJ, Gunter S, Mer M, Hsu HC, Gomes M, Norton GR, Millen AME, Dessein PH. Nesfatin-1 and visfatin expression is associated with reduced atherosclerotic disease risk in patients with rheumatoid arthritis. Peptides 2018;102:31-7. [PMID: 29475075 DOI: 10.1016/j.peptides.2018.02.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
14 González-gay MA, González-juanatey C. NSAIDs and cardiovascular risk in arthritis. Nat Rev Cardiol 2017;14:69-70. [DOI: 10.1038/nrcardio.2016.208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Castañeda S, González-Juanatey C, González-Gay MA. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases. Clin Rev Allergy Immunol 2019;56:278-92. [PMID: 28852999 DOI: 10.1007/s12016-017-8635-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
16 Berger M, Fesler P, Roubille C. Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseases. Autoimmun Rev 2021;20:102891. [PMID: 34229047 DOI: 10.1016/j.autrev.2021.102891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Łosińska K, Korkosz M, Kwaśny-Krochin B. Endothelial dysfunction in patients with ankylosing spondylitis. Reumatologia 2019;57:100-5. [PMID: 31130748 DOI: 10.5114/reum.2019.84815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Castañeda S, Vicente-Rabaneda EF, Valero C, Remuzgo-Martínez S, López-Mejías R, González-Gay MA. Effect of cardiovascular disease on chronic inflammatory joint disease: reverse causality? Expert Rev Clin Immunol 2020;16:855-8. [PMID: 32867563 DOI: 10.1080/1744666X.2020.1814146] [Reference Citation Analysis]
19 D'Agostino MA, Alten R, Mysler E, Le Bars M, Ye J, Murthy B, Heitzmann J, Vadanici R, Ferraccioli G. Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis. Clin Rheumatol 2017;36:2655-65. [PMID: 28822046 DOI: 10.1007/s10067-017-3788-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
20 Giollo A, Dalbeni A, Cioffi G, Ognibeni F, Gatti D, Idolazzi L, Orsolini G, Minuz P, Rossini M, Fava C, Viapiana O. Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease. Clin Rheumatol 2017;36:2487-95. [DOI: 10.1007/s10067-017-3786-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 von Scheidt M, Zhao Y, de Aguiar Vallim TQ, Che N, Wierer M, Seldin MM, Franzén O, Kurt Z, Pang S, Bongiovanni D, Yamamoto M, Edwards PA, Ruusalepp A, Kovacic JC, Mann M, Björkegren JLM, Lusis AJ, Yang X, Schunkert H. Transcription Factor MAFF (MAF Basic Leucine Zipper Transcription Factor F) Regulates an Atherosclerosis Relevant Network Connecting Inflammation and Cholesterol Metabolism. Circulation 2021;143:1809-23. [PMID: 33626882 DOI: 10.1161/CIRCULATIONAHA.120.050186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Lo Gullo A, Rodríguez-carrio J, Aragona CO, Dattilo G, Zito C, Suárez A, Loddo S, Atteritano M, Saitta A, Mandraffino G. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation. Atherosclerosis 2018;271:214-22. [DOI: 10.1016/j.atherosclerosis.2018.03.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Kim JH, Choi IA. Cardiovascular morbidity and mortality in patients with spondyloarthritis: A meta-analysis. Int J Rheum Dis 2021;24:477-86. [PMID: 32969177 DOI: 10.1111/1756-185X.13970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gunter S, Robinson C, Norton GR, Woodiwiss AJ, Tsang L, Millen AME, Dessein PH. Disease severity impacts the relationship of apelin with arterial function in patients with rheumatoid arthritis. Clin Rheumatol 2018;37:1481-91. [DOI: 10.1007/s10067-018-4013-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Mahtta D, Gupta A, Ramsey DJ, Rifai MA, Mehta A, Krittanawong C, Lee MT, Nasir K, Samad Z, Blumenthal RS, Jneid H, Ballantyne CM, Petersen LA, Virani SS. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. The American Journal of Medicine 2020;133:1424-1432.e1. [DOI: 10.1016/j.amjmed.2020.05.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
26 Genre F, Rueda-Gotor J, Remuzgo-Martínez S, Corrales A, Mijares V, Expósito R, Mata C, Portilla V, Blanco R, Hernández JL, Llorca J, Gualillo O, López-Mejías R, González-Gay MA. Association of circulating calprotectin with lipid profile in axial spondyloarthritis. Sci Rep 2018;8:13728. [PMID: 30213986 DOI: 10.1038/s41598-018-32199-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
27 Oliviero F, Spinella P. Benefits of Probiotics in Rheumatic Diseases. Front Nutr 2020;7:157. [PMID: 33015127 DOI: 10.3389/fnut.2020.00157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Toussirot E, Bonnefoy F, Vauchy C, Perruche S, Saas P. Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives. Front Immunol 2021;12:630170. [PMID: 33717160 DOI: 10.3389/fimmu.2021.630170] [Reference Citation Analysis]
29 Mathieu S, Couderc M, Tournadre A, Soubrier M. Cardiovascular profile in osteoarthritis: a meta-analysis of cardiovascular events and risk factors. Joint Bone Spine 2019;86:679-84. [DOI: 10.1016/j.jbspin.2019.06.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
30 Karbalaie A, Abtahi F, Fatemi A, Etehadtavakol M, Emrani Z, Erlandsson BE. Elliptical broken line method for calculating capillary density in nailfold capillaroscopy: Proposal and evaluation. Microvasc Res 2017;113:1-8. [PMID: 28414021 DOI: 10.1016/j.mvr.2017.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
31 Quartuccio L. Risk of Thrombosis in Sjögren Syndrome: The Open Question of Endothelial Function Immune-mediated Dysregulation. J Rheumatol 2017;44:1106-8. [PMID: 28765343 DOI: 10.3899/jrheum.170462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Végh E, Kerekes G, Pusztai A, Hamar A, Szamosi S, Váncsa A, Bodoki L, Pogácsás L, Balázs F, Hodosi K, Domján A, Szántó S, Nagy Z, Szekanecz Z, Szűcs G. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis. Rheumatol Int 2020;40:427-36. [DOI: 10.1007/s00296-019-04497-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
33 Castañeda S, Vicente-rabaneda EF, García-castañeda N, Prieto-peña D, Dessein PH, González-gay MA. Unmet needs in the management of cardiovascular risk in inflammatory joint diseases. Expert Review of Clinical Immunology 2020;16:23-36. [DOI: 10.1080/1744666x.2019.1699058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Antovic A, Notarnicola A, Svensson J, Lundberg IE, Holmqvist M. Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset. Arthritis Care Res (Hoboken). 2018;70:1849-1855. [PMID: 29579357 DOI: 10.1002/acr.23560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Gunter S, Robinson C, Norton GR, Woodiwiss AJ, Tsang L, Dessein PH, Millen AM. Cardiovascular Risk Factors and Disease Characteristics Are Consistently Associated with Arterial Function in Rheumatoid Arthritis. J Rheumatol 2017;44:1125-33. [DOI: 10.3899/jrheum.170029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Toussirot E. Mini-Review: The Contribution of Adipokines to Joint Inflammation in Inflammatory Rheumatic Diseases. Front Endocrinol (Lausanne) 2020;11:606560. [PMID: 33424772 DOI: 10.3389/fendo.2020.606560] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA. Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study. Arthritis Rheumatol 2019;71:351-60. [PMID: 30251476 DOI: 10.1002/art.40734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
38 Lorenzo A, Pardo E, Charca L, Pino M, Queiro R. Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis. Clin Rheumatol 2020;39:2973-9. [DOI: 10.1007/s10067-020-05088-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 González-Meléndez A, Fred-Jiménez RM, Arroyo-Ávila M, Díaz-Correa L, Pérez-Ríos N, Rodríguez N, Ríos G, Vilá LM. Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis. SAGE Open Med 2020;8:2050312120958844. [PMID: 32974020 DOI: 10.1177/2050312120958844] [Reference Citation Analysis]
40 Argnani L, Zanetti A, Carrara G, Silvagni E, Guerrini G, Zambon A, Scirè CA. Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology. Front Med (Lausanne) 2021;8:745601. [PMID: 34676228 DOI: 10.3389/fmed.2021.745601] [Reference Citation Analysis]
41 Martín-martínez MA, Castañeda S, Sánchez-alonso F, García-gómez C, González-juanatey C, Sánchez-costa JT, Belmonte-lópez MA, Tornero-molina J, Santos-rey J, Sánchez González CO, Quesada E, Moreno-gil MP, Cobo-ibáñez T, Pinto-tasnde JA, Babío-herráez J, Bonilla G, Juan-mas A, Manero-ruiz FJ, Romera-baurés M, Bachiller-corral J, Chamizo-carmona E, Uriarte-ecenarro M, Barbadillo C, Fernández-carballido C, Aurrecoechea E, Möller-parrera I, Llorca J, González-gay MA; for the CARMA Project Collaborative Group. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study—results at 5 years of follow-up. Rheumatology 2021;60:2906-15. [DOI: 10.1093/rheumatology/keaa737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Valero-Jaimes JA, López-González R, Martín-Martínez MA, García-Gómez C, Sánchez-Alonso F, Sánchez-Costa JT, González-Juanatey C, Revuelta-Evrad E, Díaz-Torné C, Fernández-Espartero C, Pérez-García C, Torrente-Segarra V, Sánchez-Nievas G, Pérez-Sandoval T, Font-Ugalde P, García-Vivar ML, Aurrecoechea E, Maiz-Alonso O, Valls-García R, Miranda-Filloy JA, Llorca J, Castañeda S, Gonzalez-Gay MA. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project. J Clin Med 2021;10:382. [PMID: 33498379 DOI: 10.3390/jcm10030382] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Sanghera C, Wong LM, Panahi M, Sintou A, Hasham M, Sattler S. Cardiac phenotype in mouse models of systemic autoimmunity. Dis Model Mech 2019;12:dmm036947. [PMID: 30858306 DOI: 10.1242/dmm.036947] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
44 Hung Y, Lin L, Wang Y, Wei JC, Wang PY, Chiou J. Combination effect of anti-rheumatic medications for coronary artery diseases risk in rheumatoid arthritis: a nationwide population-based cohort study. Current Medical Research and Opinion 2019;35:313-20. [DOI: 10.1080/03007995.2018.1492910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Buleu F, Sirbu E, Caraba A, Dragan S. Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review. Medicina (Kaunas) 2019;55:E249. [PMID: 31174287 DOI: 10.3390/medicina55060249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
46 Czókolyová M, Pusztai A, Végh E, Horváth Á, Szentpéteri A, Hamar A, Szamosi S, Hodosi K, Domján A, Szántó S, Kerekes G, Seres I, Harangi M, Paragh G, Szekanecz É, Szekanecz Z, Szűcs G. Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology. Biomolecules 2021;11:1535. [PMID: 34680168 DOI: 10.3390/biom11101535] [Reference Citation Analysis]
47 Bassi GS, Kanashiro A, Rodrigues GJ, Cunha FQ, Coimbra NC, Ulloa L. Brain Stimulation Differentially Modulates Nociception and Inflammation in Aversive and Non-aversive Behavioral Conditions. Neuroscience 2018;383:191-204. [PMID: 29772343 DOI: 10.1016/j.neuroscience.2018.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
48 Solomon A, Stanwix AE, Castañeda S, Llorca J, Gonzalez-Juanatey C, Hodkinson B, Romela B, Ally MMTM, Maharaj AB, Van Duuren EM, Ziki JJ, Seboka M, Mohapi M, Jansen Van Rensburg BJ, Tarr GS, Makan K, Balton C, Gogakis A, González-Gay MA, Dessein PH. Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country. BMC Rheumatol 2020;4:42. [PMID: 32550295 DOI: 10.1186/s41927-020-00139-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
49 Chen YJ, Liu SC, Lai KL, Tang KT, Lin CH, Chen YM, Tseng CW, Chang YM, Gotcher DF, Chiou CC, Weng SJ, Chen HH. Factors associated with risk of major adverse cardiovascular events in patients with rheumatoid arthritis: a nationwide, population-based, case-control study. Ther Adv Musculoskelet Dis 2021;13:1759720X211030809. [PMID: 34471426 DOI: 10.1177/1759720X211030809] [Reference Citation Analysis]
50 Fernández-Ortiz AM, Ortiz AM, Pérez S, Toledano E, Abásolo L, González-Gay MA, Castañeda S, González-Álvaro I. Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory? Arthritis Res Ther 2020;22:213. [PMID: 32917272 DOI: 10.1186/s13075-020-02307-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Chodara AM, Wattiaux A, Bartels CM. Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches. Curr Rheumatol Rep 2017;19:16. [PMID: 28361332 DOI: 10.1007/s11926-017-0643-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
52 Cerqueira JJ, Compston DAS, Geraldes R, Rosa MM, Schmierer K, Thompson A, Tinelli M, Palace J. Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis? J Neurol Neurosurg Psychiatry 2018;89:844-50. [PMID: 29618493 DOI: 10.1136/jnnp-2017-317509] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 18.0] [Reference Citation Analysis]
53 Taylor PC, Weinblatt ME, Burmester GR, Rooney TP, Witt S, Walls CD, Issa M, Salinas CA, Saifan C, Zhang X, Cardoso A, González-Gay MA, Takeuchi T. Cardiovascular Safety During Treatment With Baricitinib in Rheumatoid Arthritis. Arthritis Rheumatol 2019;71:1042-55. [PMID: 30663869 DOI: 10.1002/art.40841] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 32.0] [Reference Citation Analysis]
54 Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Clin Exp Immunol 2018;194:27-38. [PMID: 30208508 DOI: 10.1111/cei.13180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
55 Rueda-Gotor J, López-Mejías R, Remuzgo-Martínez S, Pulito-Cueto V, Corrales A, Lera-Gómez L, Portilla V, González-Mazón Í, Blanco R, Expósito R, Mata C, Llorca J, Hernández-Hernández V, Rodríguez-Lozano C, Barbarroja N, Castro RO, Vicente E, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Galíndez-Agirregoikoa E, García-Vivar ML, Gualillo O, Quevedo-Abeledo JC, Castañeda S, Ferraz-Amaro I, González-Gay MÁ, Genre F. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study. Arthritis Res Ther 2021;23:111. [PMID: 33849644 DOI: 10.1186/s13075-021-02499-7] [Reference Citation Analysis]
56 Hatipsoylu E, Şengül İ, Kaya T, Karatepe AG, Akçay S, Isayeva L, Bozkaya G, Tatar E. Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis. Anatol J Cardiol 2019;22:185-91. [PMID: 31584431 DOI: 10.14744/AnatolJCardiol.2019.13367] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Alonso-Molero J, Prieto-Peña D, Mendoza G, Atienza-Mateo B, Corrales A, González-Gay MÁ, Llorca J. Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis. Int J Environ Res Public Health 2020;17:E5954. [PMID: 32824469 DOI: 10.3390/ijerph17165954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]